Interview with Dr. Sean Austin and Dr. Norbert Sprenger: The diverse profile of human milk oligosaccharides (HMOs) and its significance in early life health outcomes

1 min read /
Gut health Allergies & Immunity
Interview with Dr. Sean Austin and Dr. Norbert Sprenger: The diverse profile of human milk oligosaccharides (HMOs) and its significance in early life health outcomes
  • The formation and characterization of quantifiable HMO structures
  • Tools available for assessing HMO diversity in human milk samples
  • HMO profile influenced by FUT-2 and FUT-3 gene polymorphism
  • Clinical evidence on the role of HMO diversity on early life health outcomes
Download PDF Save (for later)
Preview

WYE-EM-025-FEB -21

Reference

Other articles that you might be interested in:

Infographic – HMO Diversity

If you liked this post you may also like

WNSC Learning Lead 2024 C-Section
Restoring Gut Health in C-Section Infants: Exploring the Role of Nutrition Modulators

Restoring Gut Health in C-Section Infants: Exploring the Role of Nutrition Modulators

boy-in-toilet
[Literature library] High sn-2 palmitate infant formula and gastrointestinal (GI) tolerance

[Literature library] High sn-2 palmitate infant formula and gastrointestinal (GI) tolerance

gut-puzzles
[Literature library] Bovine milk oligosaccharides (MOS) support gut microbiota development and intestinal immune defense

[Literature library] Bovine milk oligosaccharides (MOS) support gut microbiota development and intestinal immune defense

[Literature Library] Epitope-Specific Response of Human Milk sIgA in COVID-19 Recovered Women
[Literature Library] Epitope-Specific Response of Human Milk sIgA in COVID-19 Recovered Women

[Literature Library] Epitope-Specific Response of Human Milk sIgA in COVID-19 Recovered Women